Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ben‐Chung Cheng
Safety and Efficacy of Intrarenal Arterial Autologous CD34+ Cell Transfusion in Patients With Chronic Kidney Disease: A Randomized, Open-Label, Controlled Phase II Clinical Trial
Stem cells translational medicine
Medicine
Developmental Biology
Cell Biology
Related publications
Intracoronary Injection of Autologous CD34+ Cells Improves One-Year Left Ventricular Systolic Function in Patients With Diffuse Coronary Artery Disease and Preserved Cardiac Performance—A Randomized, Open-Label, Controlled Phase II Clinical Trial
Journal of Clinical Medicine
Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial
SKIN The Journal of Cutaneous Medicine
Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Orally Active Prostacyclin Analogue Beraprost Sodium in Patients With Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Dose Finding Trial
BMC Nephrology
Nephrology
A Phase III, Multicenter, Collaborative, Open-Label Clinical Trial of Sildenafil in Japanese Patients With Pulmonary Arterial Hypertension
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Efficacy of Bimin Decoction for Patients With Perennial Allergic Rhinitis: An Open-Label Non-Inferiority Randomized Controlled Trial
Trials
Medicine
Pharmacology
Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Efficacy and Safety of Acupuncture for Patients With Chronic Urticaria: Study Protocol of a Randomized, Sham-Controlled Pilot Trial
Trials
Medicine
Pharmacology
Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results From the SPARK Open-Label, Multicentre, Randomized Phase IIIb Trial
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
